Sale!

Breast Comprehensive Panel NGS Genetic DNA Test

Original price was: $750.Current price is: $500.

-33%

The Breast Comprehensive Panel NGS Genetic DNA Test is a cutting-edge genetic screening that utilizes Next-Generation Sequencing (NGS) technology to analyze over 30 genes associated with hereditary breast cancer risk. This comprehensive test provides crucial insights into genetic mutations that may increase susceptibility to breast cancer and other related cancers. For individuals with family history of breast cancer or those seeking proactive health management, this test offers valuable information for personalized prevention strategies. The test costs $500 USD and requires a simple blood sample or extracted DNA. Results are typically available within 3-4 weeks, providing detailed genetic information that can guide medical decisions and lifestyle choices for better health outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Breast Comprehensive Panel NGS Genetic DNA Test

Comprehensive Genetic Assessment for Hereditary Breast Cancer Risk

The Breast Comprehensive Panel NGS Genetic DNA Test represents a significant advancement in personalized medicine, offering individuals unprecedented insight into their genetic predisposition for hereditary breast cancer. Utilizing state-of-the-art Next-Generation Sequencing (NGS) technology, this comprehensive screening analyzes multiple genes simultaneously, providing a thorough assessment of inherited cancer risks that can inform proactive healthcare decisions and preventive strategies.

What This Test Measures and Detects

Our advanced NGS-based panel screens for mutations across more than 30 critical genes associated with hereditary breast cancer syndromes, including:

  • BRCA1 and BRCA2 genes – the most well-known hereditary breast cancer genes
  • ATM, BARD1, and BRIP1 – DNA repair pathway genes
  • CDH1 and PTEN – tumor suppressor genes
  • CHEK2, PALB2, and TP53 – cell cycle regulation genes
  • Multiple mismatch repair genes (MLH1, MSH2, MSH6, PMS2)
  • Fanconi anemia pathway genes (FANCC, RAD51C, RAD51D)
  • And many other clinically significant genes

This comprehensive approach ensures that even rare genetic mutations contributing to breast cancer risk are identified, providing a complete picture of your hereditary cancer susceptibility.

Who Should Consider This Genetic Test

This test is particularly recommended for individuals who meet any of the following criteria:

  • Personal history of breast cancer diagnosed before age 50
  • Family history of breast, ovarian, pancreatic, or prostate cancer
  • Multiple relatives on the same side of the family with breast cancer
  • Ashkenazi Jewish ancestry with any family cancer history
  • Male breast cancer in personal or family history
  • Triple-negative breast cancer diagnosis
  • Multiple primary cancers in the same individual
  • Known family history of genetic mutations in breast cancer genes

Significant Benefits of Genetic Testing

Undergoing the Breast Comprehensive Panel NGS Genetic DNA Test offers numerous advantages:

  • Early Risk Identification: Detect genetic mutations before cancer develops
  • Personalized Screening: Tailor mammogram and MRI schedules based on genetic risk
  • Preventive Options: Consider risk-reducing medications or surgeries if indicated
  • Family Awareness: Inform relatives about potential inherited risks
  • Peace of Mind: Reduce uncertainty about hereditary cancer risks
  • Comprehensive Coverage: Single test screens multiple genes simultaneously
  • Advanced Technology: NGS provides high accuracy and comprehensive analysis

Understanding Your Test Results

Your genetic test results will fall into one of several categories, each with specific implications:

  • Positive Result: A pathogenic mutation was identified, indicating increased cancer risk. Our genetic counselors will provide detailed guidance on management options, increased surveillance, and preventive measures.
  • Negative Result: No mutations were found in the tested genes. This may provide reassurance, though it doesn’t eliminate all cancer risk.
  • Variant of Uncertain Significance (VUS): A genetic change was found, but its clinical significance is unknown. Ongoing research may provide more information over time.
  • Positive for Common Variants: Some genetic variations are common in the population and may slightly modify cancer risk.

All results are accompanied by comprehensive genetic counseling to ensure you fully understand the implications and next steps.

Test Pricing and Details

Test Feature Details
Test Name Breast Comprehensive Panel NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $750 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)

Nationwide Accessibility

We have conveniently located branches across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures that quality genetic testing is accessible to everyone, regardless of location.

Take Control of Your Health Today

Don’t leave your health to chance. Understanding your genetic predisposition to breast cancer can empower you to make informed decisions about your healthcare. Our team of genetic counselors and oncology specialists are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Breast Comprehensive Panel NGS Genetic DNA Test and take the first step toward proactive health management.

Remember: Knowledge is power when it comes to cancer prevention. Early detection of genetic risks can lead to life-saving interventions and personalized care plans designed specifically for your genetic profile.